HyrdoFrame / HydroSoft
This proposed Registry, to be conducted by South American neuro-intervention centers, will be a prospective multicenter registry of 160 patients harboring intraccranial aneurysms measuring less than 10mm in long diameter. Dr. Lemme will be the primary investigator and Dr. Miranda will be the core lab evaluator. Each target aneurysm will be treated with HydroFrame and HydroSoft coils with 50% (%total length of HyrdoFrame and HydroSoft coils) or greater HydroFrame and HydroSoft minimum.
The study will be focused on safety and efficacy of the HydroSoft coil as well as to evaluate the short term outcomes, namely recanalization at 6 months in this cohort of patients. The result of this registry will then be compared with the historical bare-platinum coil-treated patients. Patients will be evaluated by high quality DSA imageing at 6 months.